Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 10Neoplasms 5Colorectal Neoplasms 4Neoplasm Metastasis 3Prostatic Neoplasms 2Lung Neoplasms 2Vomiting 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Skin Carcinoma 1Postoperative Complications 1Polycystic Ovary Syndrome 1Peripheral Arterial Disease 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Pain 1Opioid-Related Disorders 1Nausea 1Multiple Myeloma 1Mouth Neoplasms 1Motor Activity 1Melanoma 1Medication Adherence 1Malignant Solid Neoplasm 1Lymphoma, Follicular 1Localised Prostate Cancer 1Laryngeal Neoplasms 1Ischemia 1Hypertension 1Hemianopsia 1

Interventions

Carboplatin 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2selinexor 1ponatinib 1poly ICLC 1pemigatinib 1neratinib 1donafenib 1cobimetinib 1ceritinib 1cemiplimab 1brigatinib 1abemaciclib 1Thymopentin 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiation 1Pluvicto 1Platinum Compounds 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Neck Dissection 1NF protocol 1Magnetic Resonance Spectroscopy 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma × Standard of Care × Clear all
NCT07135882 2025-08-22

PRIME-Lung

Trans Tasman Radiation Oncology Group

Phase 3 Not yet recruiting
420 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡